Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 22722516)

1.

Efficacy and safety of levetiracetam for the prevention of alcohol relapse in recently detoxified alcohol-dependent patients: a randomized trial.

Richter C, Effenberger S, Bschor T, Bonnet U, Haasen C, Preuss UW, Heinz A, Förg A, Volkmar K, Glauner T, Schaefer M.

J Clin Psychopharmacol. 2012 Aug;32(4):558-62. doi: 10.1097/JCP.0b013e31825e213e.

PMID:
22722516
2.
3.

A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients.

Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Tiouririne NA, Johnson B, Pettinati H, Strain EC, Devine E, Brunette MF, Kampman K, A Tompkins D, Stout R; NCIG 002 Study Group.

Alcohol Clin Exp Res. 2012 Aug;36(8):1421-30. doi: 10.1111/j.1530-0277.2011.01716.x. Epub 2012 Feb 10.

4.

Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.

Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM; Levetiracetam XR N01235 Study Group.

Epilepsia. 2009 Mar;50(3):406-14. doi: 10.1111/j.1528-1167.2008.01817.x.

PMID:
19317886
5.

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.

Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.

Epilepsia. 2009 Mar;50(3):398-405. doi: 10.1111/j.1528-1167.2008.01729.x. Epub 2008 Jul 24. Erratum in: Epilepsia. 2009 Apr;50(4):971.

PMID:
18657175
6.

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.

Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME.

Arch Gen Psychiatry. 2005 Jan;62(1):37-45.

PMID:
15630071
7.

Efficacy and safety of levetiracetam for outpatient alcohol detoxification.

Müller CA, Schäfer M, Schneider S, Heimann HM, Hinzpeter A, Volkmar K, Förg A, Heinz A, Hein J.

Pharmacopsychiatry. 2010 Jul;43(5):184-9. doi: 10.1055/s-0030-1249098. Epub 2010 May 25.

PMID:
20503149
9.

Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).

Consoli D, Bosco D, Postorino P, Galati F, Plastino M, Perticoni GF, Ottonello GA, Passarella B, Ricci S, Neri G, Toni D; EPIC Study.

Cerebrovasc Dis. 2012;34(4):282-9. doi: 10.1159/000342669. Epub 2012 Nov 1.

10.

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial.

Marra D, Warot D, Berlin I, Hispard E, Notides C, Tilikete S, Payan C, Lépine JP, Dally S, Aubin HJ.

Alcohol Clin Exp Res. 2002 Oct;26(10):1545-52.

PMID:
12394288
11.

Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.

Garbutt JC, Kampov-Polevoy AB, Gallop R, Kalka-Juhl L, Flannery BA.

Alcohol Clin Exp Res. 2010 Nov;34(11):1849-57. doi: 10.1111/j.1530-0277.2010.01273.x.

12.

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.

Gastpar M, Bonnet U, Böning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R.

J Clin Psychopharmacol. 2002 Dec;22(6):592-8.

PMID:
12454559
13.

Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.

Jungehulsing GJ, Israel H, Safar N, Taskin B, Nolte CH, Brunecker P, Wernecke KD, Villringer A.

Eur J Neurol. 2013 Feb;20(2):331-7. doi: 10.1111/j.1468-1331.2012.03857.x. Epub 2012 Aug 27.

PMID:
22925226
14.

Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial.

Richter C, Hinzpeter A, Schmidt F, Kienast T, Preuss UW, Plenge T, Heinz A, Schaefer M.

J Clin Psychopharmacol. 2010 Dec;30(6):720-5.

PMID:
21105289
15.

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.

Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, Agabio R, Colombo G, Gessa GL, Gasbarrini G.

Alcohol Alcohol. 2002 Sep-Oct;37(5):504-8.

16.

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial.

Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I.

Neurology. 2000 Jul 25;55(2):236-42.

PMID:
10908898
17.

Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.

Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z; N159 Study Group.

Neurology. 2006 Jun 13;66(11):1654-60. Epub 2006 Apr 26.

PMID:
16641323
19.

Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.

Förg A, Hein J, Volkmar K, Winter M, Richter C, Heinz A, Müller CA.

Alcohol Alcohol. 2012 Mar-Apr;47(2):149-55. doi: 10.1093/alcalc/agr153. Epub 2012 Jan 2.

20.

Acetyl-L-carnitine for alcohol craving and relapse prevention in anhedonic alcoholics: a randomized, double-blind, placebo-controlled pilot trial.

Martinotti G, Reina D, Di Nicola M, Andreoli S, Tedeschi D, Ortolani I, Pozzi G, Iannoni E, D'Iddio S, Janiri L.

Alcohol Alcohol. 2010 Sep-Oct;45(5):449-55. doi: 10.1093/alcalc/agq039. Epub 2010 Jun 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk